Avanos Medical (AVNS) Retained Earnings (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Retained Earnings data on file, last reported at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 0.78% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 0.78% YoY), and the FY2025 full-year result was $1.7 billion, up 0.79% from the prior year.
• Retained Earnings was little changed at $1.7 billion in Q1 2026, from $1.7 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.7 billion in Q1 2026 to a low of -$315.8 million in Q1 2024.
• A 5-year average of $1.1 billion and a median of $1.7 billion in 2023 frame the typical range for Retained Earnings.
• Peak annual rise in Retained Earnings reached 5985.56% in 2024, while the deepest fall reached 119.13% in 2024.
• Tracing AVNS's Retained Earnings over 5 years: stood at $1.6 billion in 2022, then gained by 1.04% to $1.7 billion in 2023, then increased by 0.9% to $1.7 billion in 2024, then advanced by 0.79% to $1.7 billion in 2025, then gained by 0.24% to $1.7 billion in 2026.
• Business Quant data shows AVNS's Retained Earnings at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and -$32.6 million in Q3 2025.